Aberrant DNA methylation of miR-219 promoter in long-term night shiftworkers

Environmental and Molecular Mutagenesis

Volumn 54, Issue 6, 2013, Pages 406-413

  Shi, Fengqin ^a,b   Chen, Xinyi ^b   Fu, Alan ^a   Hansen, Johnni ^c   Stevens, Richard ^d   Tjonneland, Anne ^c   Vogel, Ulla B ^e   Zheng, Tongzhang ^a   Zhu, Yong ^a  

^a YALE UNIVERSITY   (United States)

^b BEIJING UNIVERSITY OF CHINESE MEDICINE   (China)

^c INSTITUTE OF CANCER EPIDEMIOLOGY   (Denmark)

^d UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

^e NATIONAL RESEARCH CENTRE FOR THE WORKING ENVIRONMENT   (Denmark)

Author keywords

Breast cancer; Methylation; MicroRNAs; MiR 219; Shiftwork

Indexed keywords

DNA; MICRORNA; MICRORNA 219; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BREAST CANCER; CANCER CELL; CPG ISLAND; DNA METHYLATION; GENE OVEREXPRESSION; HUMAN; NIGHT WORK; PROMOTER REGION; SHIFT WORKER;

BREAST CANCER; METHYLATION; MICRORNAS; MIR-219; SHIFTWORK;

APOPTOSIS; BREAST NEOPLASMS; CELL LINE, TUMOR; CPG ISLANDS; DNA METHYLATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MICRORNAS; MIDDLE AGED; NF-KAPPA B; OCCUPATIONAL DISEASES; PROMOTER REGIONS, GENETIC; RISK; WORK SCHEDULE TOLERANCE;

EID: 84880043634     PISSN: 08936692     EISSN: 10982280     Source Type: Journal    
DOI: 10.1002/em.21790     Document Type: Article

References (41)

1. Belardelli F, Ferrantini M, Proietti E, Kirkwood JM. 2002. Interferon-alpha in tumor immunity and immunotherapy. Cytokine Growth Factor Rev 13:119-134.
2. Calvano SE, Xiao W, Richards DR, Felciano RM, Baker HV, Cho RJ, Chen RO, Brownstein BH, Cobb JP, Tschoeke SK, Miller-Graziano C, Moldawer LL, Mindrinos MN, Davis RW, Tompkins RG, Lowry SF. 2005. A network-based analysis of systemic inflammation in humans. Nature 437:1032-1037.
3. Chebath J, Benech P, Revel M, Vigneron M. 1987. Constitutive expression of (2′-5′) oligo A synthetase confers resistance to picornavirus infection. Nature 330:587-588.
4. Cheng HY, Papp JW, Varlamova O, Dziema H, Russell B, Curfman JP, Nakazawa T, Shimizu K, Okamura H, Impey S, Obrietan K. 2007. microRNA modulation of circadian-clock period and entrainment. Neuron 54:813-829.
5. Chiocca EA. 2002. Oncolytic viruses. Nat Rev Cancer 2:938-950.
6. Croce CM, Calin GA. 2005. miRNAs, cancer, and stem cell division. Cell 122:6-7.
7. Cui H, Cruz-Correa M, Giardiello FM, Hutcheon DF, Kafonek DR, Brandenburg S, Wu Y, He X, Powe NR, Feinberg AP. 2003. Loss of IGF2 imprinting: A potential marker of colorectal cancer risk. Science 299:1753-1755.
8. de Veer MJ, Holko M, Frevel M, Walker E, Der S, Paranjape JM, Silverman RH, Williams BRG. 2001. Functional classification of interferon-stimulated genes identified using microarrays. J Leukoc Biol 69:912-920.
9. Fu A, Leaderer D, Zheng T, Hoffman AE, Stevens RG, Zhu Y. 2012. Genetic and epigenetic associations of circadian gene TIMELESS and breast cancer risk. Mol Carcinog 51:923-929.
10. Furuta M, Kozaki KI, Tanaka S, Arii S, Imoto I, Inazawa J. 2010. miR-124 and miR-203 are epigenetically silenced tumor-suppressive microRNAs in hepatocellular carcinoma. Carcinogenesis 31:766-776.
11. Gao W, Kondo Y, Shen L, Shimizu Y, Sano T, Yamao K, Natsume A, Goto Y, Ito M, Murakami H, Osada H, Zhang J, Issa JP, Sekido Y. 2008. Variable DNA methylation patterns associated with progression of disease in hepatocellular carcinomas. Carcinogenesis 29:1901-1910.
12. Hansen J, Stevens RG. 2012. Case-control study of shift-work and breast cancer risk in Danish nurses: Impact of shift systems. Eur J Cancer 48:1722-1729.
13. Hinoue T, Weisenberger DJ, Lange CP, Shen H, Byun HM, Van Den Berg D, Malik S, Pan F, Noushmehr H, van Dijk CM, Tollenaar RA, Laird PW. 2012. Genome-scale analysis of aberrant DNA methylation in colorectal cancer. Genome Res 22:271-282.
14. Hoffman AE, Yi CH, Zheng T, Stevens RG, Leaderer D, Zhang Y, Holford TR, Hansen J, Paulson J, Zhu Y. 2010a. CLOCK in breast tumorigenesis: Genetic, epigenetic, and transcriptional profiling analyses. Cancer Res 70:1459-1468.
15. Hoffman AE, Zheng T, Yi CH, Stevens RG, Ba Y, Zhang Y, Leaderer D, Holford T, Hansen J, Zhu Y. 2010b. The core circadian gene Cryptochrome 2 influences breast cancer risk, possibly by mediating hormone signaling. Cancer Prev Res (Phila) 3:539-548.
16. Jacobs DI, Hansen J, Fu A, Stevens RG, Tjonneland A, Vogel UB, Zheng T, Zhu Y. 2013. Methylation alterations at imprinted genes detected among long-term shiftworkers. Environ Mol Mutagen 54:141-146.
17. Jordan WJ, Eskdale J, Boniotto M, Rodia M, Kellner D, Gallagher G. 2007. Modulation of the human cytokine response by interferon lambda-1 (IFN-lambda 1/IL-29). Genes Immun 8:13-20.
18. Kadener S, Menet JS, Sugino K, Horwich MD, Weissbein U, Nawathean P, Vagin VV, Zamore PD, Nelson SB, Rosbash M. 2009. A role for microRNAs in the Drosophila circadian clock. Genes Dev 23:2179-2191.
19. Kim YI. 2004. Folate and DNA methylation: A mechanistic link between folate deficiency and colorectal cancer? Cancer Epidemiol Biomark Prevent 13:511-519.
20. Kunej T, Godnic I, Ferdin J, Horvat S, Dovc P, Calin GA. 2011. Epigenetic regulation of microRNAs in cancer: An integrated review of literature. Mutat Res Fundam Mol Mech Mutagen 717:77-84.
21. Lawson JS, Glenn WK, Salmons B, Ye YL, Heng B, Moody P, Johal H, Rawlinson WD, Delprado W, Lutze-Mann L, Whitaker NJ. 2010. Mouse mammary tumor virus-like sequences in human breast cancer. Cancer Res 70:3576-3585.
22. Liu F, Bardhan K, Yang D, Thangaraju M, Ganapathy V, Waller JL, Liles GB, Lee JR, Liu K. 2012. NF-kappaB directly regulates Fas transcription to modulate Fas-mediated apoptosis and tumor suppression. J Biol Chem 287:25530-25540.
23. Liu KH, Wang RQ. 2012. MicroRNA-mediated regulation in the mammalian circadian rhythm. J Theoret Biol 304:103-110.
24. Livak KJ, Schmittgen TD. 2001. Analysis of relative gene expression data using real-time quantitative PCR and the 2(T)(-Delta Delta C) method. Methods 25:402-408.
25. Luo W, Sehgal A. 2012. Regulation of circadian behavioral output via a MicroRNA-JAK/STAT circuit. Cell 148:765-779.
26. Mok MTS, Lawson JS, Iacopetta BJ, Whitaker NJ. 2008. Mouse mammary tumor virus-like env sequences in human breast cancer. Int J Cancer 122:2864-2870.
27. Pronk A, Ji BT, Shu XO, Xue S, Yang G, Li HL, Rothman N, Gao YT, Zheng W, Chow WH. 2010. Night-shift work and breast cancer risk in a cohort of Chinese women. Am J Epidemiol 171:953-959.
28. Qin XQ, Tao N, Dergay A, Moy P, Fawell S, Davis A, Wilson JM, Barsoum J. 1998. Interferon-beta gene therapy inhibits tumor formation and causes regression of established tumors in immune-deficient mice. Proc Natl Acad Sci USA 95:14411-14416.
29. Rauch TA, Wang Z, Wu X, Kernstine KH, Riggs AD, Pfeifer GP. 2012. DNA methylation biomarkers for lung cancer. Tumour Biol 33:287-296.
30. Reed VA. 2011. Shift work, light at night, and the risk of breast cancer a guide to administrative action for health care institutions. AAOHN J 59:37-45.
31. Rusch L, Zhou AM, Silverman RH. 2000. Caspase-dependent apoptosis by 2′, 5′-oligoadenylate activation of RNase L is enhanced by IFN-beta. J Interferon Cytokine Res 20:1091-1100.
32. Ryan BM, Robles AI, Harris CC. 2010. Genetic variation in microRNA networks: The implications for cancer research. Nat Rev Cancer 10:389-402.
33. Tjonneland A, Olsen A, Boll K, Stripp C, Christensen J, Engholm G, Overvad K. 2007. Study design, exposure variables, and socioeconomic determinants of participation in Diet, Cancer and Health: A population-based prospective cohort study of 57, 053 men and women in Denmark. Scand J Public Health 35:432-441.
34. Wang XS, Armstrong ME, Cairns BJ, Key TJ, Travis RC. 2011. Shift work and chronic disease: The epidemiological evidence. Occup Med (Lond) 61:78-89.
35. Widschwendter M, Apostolidou S, Raum E, Rothenbacher D, Fiegl H, Menon U, Stegmaier C, Jacobs IJ, Brenner H. 2008. Epigenotyping in peripheral blood cell DNA and breast cancer risk: A proof of principle study. PLoS One 3:e2656.
36. Wong TS, Liu XB, Wong BYH, Ng RWM, Yuen APW, Wei WI. 2008. Mature miR-184 as potential oncogenic microRNA of squamous cell carcinoma of tongue. Clin Cancer Res 14:2588-2592.
37. Xu XR, Gammon MD, Hernandez-Vargas H, Herceg Z, Wetmur JG, Teitelbaum SL, Bradshaw PT, Neugut AI, Santella RM, Chen J. 2012. DNA methylation in peripheral blood measured by LUMA is associated with breast cancer in a population-based study. FASEB J 26:2657-2666.
38. Yanaihara N, Caplen N, Bowman E, Seike M, Kumamoto K, Yi M, Stephens RM, Okamoto A, Yokota J, Tanaka T, Calin GA, Liu CG, Croce CM, Harris CC. 2006. Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. Cancer Cell 9:189-198.
39. Zapata-Benavides P, Saavedra-Alonso S, Zamora-Avila D, Vargas-Rodarte C, Barrera-Rodriguez R, Salinas-Silva J, Rodriguez-Padilla C, Tamez-Guerra R, Trejo-Avila L. 2007. Mouse mammary tumor virus-like gene sequences in breast cancer samples of Mexican women. Intervirology 50:402-407.
40. Zhu Y, Stevens RG, Hoffman AE, Tjonneland A, Vogel UB, Zheng TZ, Hansen J. 2011. Epigenetic impact of long-term shiftwork: Pilot evidence from circadian genes and whole-genome methylation analysis. Chronobiol Int 28:852-861.
41. Zhu Y, Stevens RG, Leaderer D, Hoffman A, Holford T, Zhang Y, Brown HN, Zheng T. 2008. Non-synonymous polymorphisms in the circadian gene NPAS2 and breast cancer risk. Breast Cancer Res Treat 107:421-425.